Wilson's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials
• Forums

ALXN1840 FoCus Phase III Trial in Wilson Disease Met Primary Endpoint Demonstrating Improvement in Copper Mobilisation from Tissues
26 August 2021  ALXN1840 demonstrated approximately three times greater copper mobilisation from tissues than standard-of-care treatments  Positive high-level results from the FoCus Phase III trial in Wilson disease showed ALXN1840... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 26, 2021 Category: Pharmaceuticals Source Type: clinical trials

Impact of the Lockdown Due to the COVID Pandemic in French Wilson's Disease Patients
Condition:   Wilson's Disease and COVID-19 Intervention:   Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2021 Category: Research Source Type: clinical trials